Vida Pharma
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Vida Pharma - overview
Established
2004
Location
Tuscany, -, Italy
Primary Industry
Consumer Products
About
Founded in 2004 by Dario Scaffai (Director) and based in Tuscany, Italy, Vida Srl doing business as Vida Pharma operates as a manufacturer of cosmetic products, medical devices, and medical-surgical devices. In April 2024, White Bridge Investments II acquired a majority stake in Vida Pharma. The firm as of April 2024, has offices in Crespina Lorenzana (PI) and Assago (MI), Italy. The company enables individuals to experience beauty in all its forms.
Vida Pharma's flagship brand, Ksurgery, offers a wide range of 100% Made in Italy cosmetic and professional products. Ksurgery provides aesthetic medicine treatments such as fillers and biorevitalizers based on hyaluronic acid for the face and body and of cosmetics, including peelings and mesotherapy, emphasizing safety, ease of application, treatment duration, and aesthetic outcomes. Additionally, Vidapharma collaborates with international partner Skeyndor to provide trusted products. The April 2024 acquisition will support Vida Pharma to expand its service offerings and geographic market presence through organic growth initiatives and acquisitions.
Current Investors
White Bridge Investments
Primary Industry
Consumer Products
Sub Industries
Beauty & Hygiene
Website
www.vidapharma.it
Verticals
Manufacturing
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Vida Pharma - timeline of key events
Vida Pharma - financials
| Fiscal Year Ended | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|
| Revenue (USD) | 3,381,520 | 3,862,017 | 6,680,346 | - | - | - |
| % Revenue Growth (YoY) | - | 14.2% | 73.0% | - | - | - |
| EBITDA (USD) | 170,369 | 325,623 | 2,341,075 | - | - | - |
| Operating Income (USD) | 152,819 | 296,101 | 2,279,128 | - | - | - |
| Operating Margin | 4.5% | 7.7% | 34.1% | - | - | - |
| % EBITDA Margin | 5.0% | 8.4% | 35.0% | - | - | - |
| NET Income (USD) | 94,232 | 192,812 | 1,625,044 | - | - | - |
| % Net Margin | 2.8% | 5.0% | 24.3% | - | - | - |
Vida Pharma - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | Vida Pharma | - |
Displaying 1 - 1 of 1
Vida Pharma - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.